Skip to main content
Clinical Trials/NCT06682065
NCT06682065RecruitingNot Applicable

Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling

Karolinska Institutet2 sites in 1 country510 target enrollmentStarted: May 5, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
510
Locations
2
Primary Endpoint
Use of LARC (IUD or progestin implant) at 12 week follow-up

Study Overview

Brief Summary

Overall purpose of the PILOT and RCT:

This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:

Detailed Description

Overall purpose of the PILOT and RCT:

This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:

  1. To design and test a user-friendly online service for contraceptive counseling informed by systematic research into the preference and experience of women in our study setting.
  2. To compare uptake of long-acting reversible contraception (LARC) after TECC and in-person contraceptive counseling.
  3. To compare rates of choice, uptake, and continuation of LARC or any contraceptive, satisfaction, preference for counseling, recurrent unintended pregnancy, and recurrent abortion after TECC and in-person contraceptive counseling.

PILOT STUDY Objective: To assess the acceptability of a new online e-health service for contraceptive counselling i.e., telemedicine contraceptive counseling (TECC)

Design: A mixed methods pilot study developing and testing a new TECC service preceding a randomized controlled trial Setting and duration: The study will take place at Mitchell's Plain's community health center (CHC) in Western Cape, between February November 2023 and December 2023.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Seeking either surgical or medical abortion
  • •≥ 18 years of age
  • •Able to communicate and understand spoken and written English
  • •With private access to a smart phone
  • •Willing to participate in the study procedures

Exclusion Criteria

  • Not provided

Arms & Interventions

Telemedicine

Experimental

WhatsApp algorithmic chatbot see further description

Intervention: Telemedicine for contraceptive counseling (TECC) (Other)

Standard Care

Active Comparator

Standard of care contraceptive counseling with clinic nurse

Intervention: Standard Care (Other)

Outcomes

Primary Outcomes

Use of LARC (IUD or progestin implant) at 12 week follow-up

Time Frame: 12 weeks

Proportion of participants in each arm with using LARC (IUD or progestin implant) at 12 week follow-up

Secondary Outcomes

  • Choice of LARC on day of consultation(Baseline)
  • Use of LARC at 6 months(6 months)
  • Use of LARC at 12 months(12 months)
  • Unplanned pregnancy within 6 months(6 months)
  • Unplanned pregnancy within 12 months(12 months)
  • Recurrent abortion within 6 months(6 months)
  • Recurrent abortion within 12 months(12 months)
  • Preference for counseling model(Baseline)
  • Satisfaction with contraceptive counseling(Baseline)
  • Decision-competence after contraceptive counseling(Baseline)
  • Agency in contraceptive decision making(Baseline)
  • Change of contraceptive method(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Margit Endler

Associate Professor, MD ObGyn

Karolinska Institutet

Study Sites (2)

Loading locations...

Similar Trials